Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma

Background Although most studies of anticancer T-cell immunity focus on αβ T cells, γδ T cells are attracting increasing attention due to their involvement in antitumor immune responses in various cancer entities, including melanoma. While immune checkpoint blockade (ICB) using the antagonistic prog...

Descrición completa

Detalles Bibliográficos

Principais autores:	Susanne Sebens, Teresa Amaral, Benjamin Weide, Graham Pawelec, Thomas Eigentler, Claus Garbe, Patrick Terheyden, Friedegund Meier, Kilian Wistuba-Hamprecht, Alfred Königsrainer, Nikolaus B Wagner, Jonas Bochem, Janine Spreuer, Karolin Thiel, Can Yurttas, Daniel Soffel, Stephan Forchhammer, Markus W Löffler, Sarina Ravens, Immo Prinz, Manfred Claassen, Daniela Wesch, Nicola Herold, Johanna Leyens, Svenja Wingerter, Malte Deseke, Paola Nocerino, Rita Antunes dos Reis, Kristin Bieber, Hans-Heinrich Oberg, Shahram Kordasti
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMJ Publishing Group 2026-01-01
Series:	Journal for ImmunoTherapy of Cancer
Acceso en liña:	https://jitc.bmj.com/content/14/1/e011224.full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!